Sign in

European Respiratory Society

@europeanrespsoc.bsky.social
211 followers 22 following 922 posts

A non-profit organisation dedicated to sharing scientific knowledge, fighting lung disease and promoting lung health. ERS has more than 35,000 members worldwide. ersnet.org

PostsRepliesMedia
European Respiratory Society @europeanrespsoc.bsky.social · 10h
European Respiratory Review: Use of closed-loop oxygen control in adults receiving noninvasive oxygen improves the accuracy of oxygen delivery and represents an effective strategy for achieving a target oxygen saturation range in acute inpatient care. bit.ly/4znFoqr
000
European Respiratory Society @europeanrespsoc.bsky.social · 10/10/2026
ERR: DPP1 inhibitors reduce exacerbations and may slow progression of bronchiectasis, validating inflammation as a key therapeutic target. Further investigation into their long-term efficacy, safety and treatment benefit across populations is needed. bit.ly/3UnM9s1
000
European Respiratory Society @europeanrespsoc.bsky.social · 09/10/2026
More than 50 students and trainees benefitted from free registration and mentorship at this year’s #ERSCongress! New for this year, each student was assigned an ERS Early-Career Member to provide 1:1 mentorship throughout the event! Read more: bit.ly/4yIg2Tx
000
European Respiratory Society @europeanrespsoc.bsky.social · 09/10/2026
Inflammasomes are central to respiratory diseases; however, to date, there is currently no clear reference publication that summarises the role of different inflammasomes and therapeutics in respiratory disease. This review addresses this knowledge gap. bit.ly/4fFnAzf
000
European Respiratory Society @europeanrespsoc.bsky.social · 09/10/2026
October is #PCDAwarenessMonth 🌍 Primary ciliary dyskinesia (PCD) is a rare genetic condition where cilia in the airways do not move properly. @European_Lung has a range of resources available which healthcare professionals can share with their patients: bit.ly/4hPK6oM
000
European Respiratory Society @europeanrespsoc.bsky.social · 08/10/2026
Eur Respir Rev: Physiologically relevant infection models should be benchmarked against clinical samples using omics data and quantitative accuracy scores to obtain clinically relevant insights into Pseudomonas aeruginosa cystic fibrosis lung infections. bit.ly/3TWeENm
121
European Respiratory Society @europeanrespsoc.bsky.social · 08/10/2026
This ERJ Open Research editorial discusses the article on DNA methylation in bronchiectasis by Perea et al. showing that severe bronchiectasis is associated with a distinct whole-blood DNA methylation signature, and discusses the importance of the findings bit.ly/3SGjvSw
000
European Respiratory Society @europeanrespsoc.bsky.social · 07/10/2026
European Respiratory Review: Concurrent use of opioids and stimulants are rising. This public health concern is a call to action for further research investigating the mechanisms these drugs act on to advance prevention and treatment. bit.ly/4xzTJOG
000
European Respiratory Society @europeanrespsoc.bsky.social · 07/10/2026
Join us in Heidelberg, Germany next month for an ERS skills course on interventional bronchoscopy! Through hands-on workshops, participants will have the opportunity to practice live flexible and rigid bronchoscopy on airway models. Learn more: bit.ly/4ybkdWx
000
European Respiratory Society @europeanrespsoc.bsky.social · 07/10/2026
Apply now for a new ERS Research Seminar – Identifying a path towards implementation of respiratory oscillometry into research and clinical care! This seminar aims to identify key research gaps and establish priorities for future work. Learn more: bit.ly/3UcLv0S
000
European Respiratory Society @europeanrespsoc.bsky.social · 07/10/2026
ERJ Open Research: Bronchiectasis shows distinct immune dysregulation, with depletion of FCER1G+ NK-cells and reduced CXCR4 in monocytes, highlighting innate immune disruption as a driver of disease progression bit.ly/4mhw9C2
000
European Respiratory Society @europeanrespsoc.bsky.social · 06/10/2026
The latency between smoking debut and lung cancer diagnosis in Norwegian ever-smokers is much longer than what has previously been reported, and time to diagnosis in women and current smokers is shorter compared to men and former smokers, respectively bit.ly/4e64HDv
000
European Respiratory Society @europeanrespsoc.bsky.social · 05/10/2026
ERJOR: In chronic airway diseases, initiation of inhaled antibiotic therapy is largely driven by microbiological isolation, and occurs both in stable conditions and during periods of clinical instability, with exacerbations remaining an important trigger bit.ly/3OPpUJv
121
European Respiratory Society @europeanrespsoc.bsky.social · 05/10/2026
A multicomponent asthma care model delivered sustained reductions in preventable hospitalisations and meaningful improvements in asthma control and quality of life for rural children. The model offers a replicable approach for underserved populations. bit.ly/3OZaB0S
000
European Respiratory Society @europeanrespsoc.bsky.social · 04/10/2026
ERJOR: Noninvasive ventilation during exercise improves endurance and reduces dyspnoea (showing a significant dose–response relationship) and PCO2 in COPD. Evidence supports its targeted use during pulmonary rehabilitation, particularly in severe disease. bit.ly/48EElXb
000
European Respiratory Society @europeanrespsoc.bsky.social · 03/10/2026
ERJ Open Research: Among patients with severe pulmonary hypertension associated with COPD, acute pulmonary vasoreactivity identified a subgroup with better haemodynamic response to approved PAH therapies and long-term survival bit.ly/4tt1y7h
010
European Respiratory Society @europeanrespsoc.bsky.social · 02/10/2026
ERJOR: BMPR2 mRNA expression is significantly reduced across all assessed PH subgroups, indicating a potential general impairment of BMPR2 signalling. BMPR2 mRNA and BMP10 protein expression in blood may serve as novel biomarkers for disease severity. bit.ly/4trUrvD
000
European Respiratory Society @europeanrespsoc.bsky.social · 02/10/2026
In high-altitude residents diagnosed with PAH, low-dose SOT via portable concentrator did not improve 6MWD or dyspnoea perception, most likely due to insufficient flow during exercise, exertional mouth breathing and the weight of the concentrator bit.ly/4vNxFzU
000
European Respiratory Society @europeanrespsoc.bsky.social · 02/10/2026
European Respiratory Journal: snRNA-seq analysis of RAS lungs revealed the general principle of an entity-spanning composition of the usual fibrotic niche consisting of aberrant basaloid cells, ectopic COL15A1+ pVECs, and CTHRC1+ fibroblasts bit.ly/3QdPRmf
010
European Respiratory Society @europeanrespsoc.bsky.social · 01/10/2026
Join ERS, PATS & Société de Pneumologie de Langue Française (SPLF) in Nairobi on 10–11 October for The world's first lung health resolution www.ersnet.org/events/the-worlds-fi…
000
European Respiratory Society @europeanrespsoc.bsky.social · 01/10/2026
Two weeks left to apply to organise your own research seminar! Apply now: www.ersnet.org/science-and-research…
000
European Respiratory Society @europeanrespsoc.bsky.social · 01/10/2026
European Respiratory Review: T-NETs are rare, aggressive and biologically distinct. Thymus-specific molecular subtyping plus spatial immune profiling can move care beyond extrapolated regimens toward biomarker-guided combinations and dedicated trials. bit.ly/4yb7OU1
000
European Respiratory Society @europeanrespsoc.bsky.social · 01/10/2026
ERJ Podcast: @profjdchalmers.bsky.social interviews editorial board member Christina Thornton and associate editor Marcus Mall about their Back to Basics review article on bridging the airway microbiome and targeted therapy in bronchiectasis ow.ly/VZR150ZRmyh
ow.ly
ERJ Podcast September 2026: The airway microbiome and targeted therapy in bronchiectasis
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Christina Thornton and ass
000
European Respiratory Society @europeanrespsoc.bsky.social · 30/09/2026
European Respiratory Review: PVOD-like disease in CTD-PAH is a high-risk phenotype marked by progressive venular remodelling, diagnostic challenges and therapeutic uncertainty. Improved stratification and dedicated treatment strategies are urgently needed. bit.ly/4wdg43T
000
European Respiratory Society @europeanrespsoc.bsky.social · 30/09/2026
European Respiratory Review: A scoping review of the impacts on maternal health and fetal outcomes of CFTR modulator use during pregnancy in cystic fibrosis bit.ly/4vGZdpQ
bit.ly
Attention Required! | Cloudflare
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL c...
000
European Respiratory Society @europeanrespsoc.bsky.social · 30/09/2026
📆 18–20 March, 2027 📍 Estoril, Portugal (and online) Don’t miss out on #LSC2027 ‘Programming lung health across the life course’. Submit your abstract before the deadline – 30 October: channel.ersnet.org/hp-545-1-abstrac…
000
European Respiratory Society @europeanrespsoc.bsky.social · 30/09/2026
Misinformation puts patients at risk. Dr Maria Neira explains why health professionals must respond by communicating clearly. Support our campaign to #DefendScience & #ProtectHealth: www.ersnet.org/advocacy/campaign-de… @europeanlung.bsky.social
011
European Respiratory Society @europeanrespsoc.bsky.social · 30/09/2026
ERR: Occlusive CPAP delivers accurate pressure and should be first-line treatment for preterm infants with RDS. Non-occlusive interfaces reduce nasal trauma but underdeliver pressure by 2–3 cmH2O. The interface should be matched to the patient's needs. bit.ly/4dLyDWM
bit.ly
Attention Required! | Cloudflare
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL c...
001
European Respiratory Society @europeanrespsoc.bsky.social · 28/09/2026
Apply for ‘Putting pieces of the puzzle together: Multimodal personalised sleep apnoea treatment’ before 15 November! The outcomes of this seminar will include a report submitted to an ERS journal & a hot-topic session at the next ERS Congress Learn more: bit.ly/44tUA6V
000
European Respiratory Society @europeanrespsoc.bsky.social · 28/09/2026
📹 Guidelines in Focus: ERS/ESCMID State-of-the-Science Statement on RDTs for community respiratory infections Watch the interview and read more: channel.ersnet.org/channel-38-guide…
000
European Respiratory Society @europeanrespsoc.bsky.social · 28/09/2026
ERJ Open Research: Inhaled rhGM-CSF (molgramostim) in 46 patients with CAP-related ARDS was safe and promoted favourable alveolar macrophage, oxygenation and SOFA score profiles, providing a strong rationale for further evaluation in pneumonia/ARDS bit.ly/47xDZ4i
000
European Respiratory Society @europeanrespsoc.bsky.social · 27/09/2026
ERJ Open Research: Treatment of patients with bronchiectasis with hypertonic saline or carbocisteine does not significantly reduce sputum viscoelastic properties and biomarker levels or alter bacterial community composition bit.ly/4r2X2KA
121
European Respiratory Society @europeanrespsoc.bsky.social · 26/09/2026
ERJOR: Long-term observation of inflammation measured in nasal lavage samples after starting ETI therapy showed a sustained effect in paediatric patients, with levels comparable to healthy controls, while in adult patients, inflammation tended to increase bit.ly/4dnenKP
000
European Respiratory Society @europeanrespsoc.bsky.social · 25/09/2026
📖 The new ERS Monograph on “Obstructive and Central Sleep Apnoea” is out now. 📖 Order your print copy: www.ersbookshop.com/products/osa 📖 Access online: publications.ersnet.org/content/boo…
000
European Respiratory Society @europeanrespsoc.bsky.social · 25/09/2026
ERJ Open Research: ESI represents a potentially valuable indicator in epidemiological surveys on the general population, as it reflects current respiratory health status and demonstrates predictive capacity for future hospitalisations bit.ly/4u2ynbN
000
European Respiratory Society @europeanrespsoc.bsky.social · 25/09/2026
Breathe: An interactive case report discussing a case of eosinophilic pleural effusion bit.ly/4eTX8QP
000
European Respiratory Society @europeanrespsoc.bsky.social · 24/09/2026
ERJ Open Research: CPA/ABPA overlap represents a distinct clinical phenotype in individuals with CPA associated with underlying airway disease, antifungal resistance and Th2-driven inflammation, with rising biomarkers linked to disease progression bit.ly/4eR5Xwv
000
European Respiratory Society @europeanrespsoc.bsky.social · 24/09/2026
Not all severe CAP is the same. Haemoptysis, cavitation and rapid deterioration should raise suspicion for Panton–Valentine leukocidin-driven disease. Early toxin-targeted therapy and recognition of mixed septic–cardiogenic shock may be key to survival. bit.ly/49KWALg
000
European Respiratory Society @europeanrespsoc.bsky.social · 23/09/2026
Post hoc analyses of the AReSVi-006 trial suggest that one dose of adjuvanted RSVPreF3 may help prevent RSV-related illness and complications over three consecutive RSV seasons in subgroups of ≥60-year-olds with chronic medical conditions e.g. COPD/asthma bit.ly/4mNNd2I
000
European Respiratory Society @europeanrespsoc.bsky.social · 23/09/2026
Breathe: Structural sequelae after TB underpin infectious PTLD: bacterial, fungal and non-TB mycobacterial. Complications are frequent yet under-diagnosed, worsening mortality and quality of life. bit.ly/4viER5M
111
European Respiratory Society @europeanrespsoc.bsky.social · 22/09/2026
ERJ Open Research: In adults, after hospitalisation for COVID-19, GPPAQ shows internal/construct validity and modest convergence with device-measured MVPA. Despite limits, its brevity makes it a practical, low-cost screener for physical inactivity. bit.ly/4166H8L
000
European Respiratory Society @europeanrespsoc.bsky.social · 22/09/2026
Breathe: Fusion gene alterations in NSCLC are transforming care. Respiratory physicians have a key role in ensuring quality tissue sampling and molecular testing for fusions, enabling timely targeted therapy and better patient outcomes. bit.ly/4fxVS80
010
European Respiratory Society @europeanrespsoc.bsky.social · 22/09/2026
🚨 CME credits and certificates of attendance for the #ERSCongress 2026 are now available 🚨 Complete the mandatory Congress evaluation survey and claim your credits via the ERS CME platform by 30 December, 2026. Learn more: bit.ly/4ou1Bx7
000
European Respiratory Society @europeanrespsoc.bsky.social · 21/09/2026
We agree with EU Commission President @vonderleyen.ec.europa.eu: #AI is no substitute for trained health professionals. Europe’s policymakers can #ProtectHealth by funding healthcare, vetting tech and tackling misinformation: www.ersnet.org/advocacy/campaign-de…
010
European Respiratory Society @europeanrespsoc.bsky.social · 21/09/2026
Breathe: Respiratory physiotherapy plays an important role in cough augmentation in patients with Duchenne muscular dystrophy. Early intervention is crucial in slowing the decline of pulmonary function and improving quality of life in this patient cohort. bit.ly/4i5yRug
bit.ly
Attention Required! | Cloudflare
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL c...
100
European Respiratory Society @europeanrespsoc.bsky.social · 21/09/2026
ERJ Open Research: Creatine supplementation is associated with greater increases in PImax following IMT in healthy humans and improved diaphragm contractile performance in a preclinical model of heart failure bit.ly/4cxAaid
000
European Respiratory Society @europeanrespsoc.bsky.social · 20/09/2026
Breathe: An overview of the pathophysiological mechanisms underlying respiratory dysfunction in children with neurodevelopmental conditions, outlining assessment strategies and evaluating current interventions aimed at optimising respiratory health bit.ly/4y1tlyt
bit.ly
000
European Respiratory Society @europeanrespsoc.bsky.social · 20/09/2026
ERJ Open Research: Respiratory symptoms were frequently observed in children and adolescents living in areas with high exposure to volcanic emissions. DLCO and FENO may help identify abnormalities despite normal spirometry in this population. bit.ly/4dmo9eZ
042
European Respiratory Society @europeanrespsoc.bsky.social · 19/09/2026
Preclinical models are essential to link specific features of spinal cord injury to respiratory dysfunction and to study recovery. Using complementary models ensures clinically relevant insights and avoids misleading conclusions from any single paradigm. bit.ly/4aYSRdD
000
European Respiratory Society @europeanrespsoc.bsky.social · 19/09/2026
ERJOR: Laryngeal ultrasound enables noninvasive assessment of upper airway responses during mechanically assisted cough. Despite less consistent visualisation than laryngoscopy, concordance is relatively high, supporting its role as a bedside adjunct. bit.ly/4uQgZXk
000